A phase I trial of nordihydroguareacetic acid (NDGA) in patients with non-metastatic prostate cancer and rising PSA

被引：0
|
作者：
Harzstark, A. L. [1 ]
Ryan, C. [1 ]
Diamond, M. [1 ]
Jones, J. [1 ]
Zavodovskaya, M. [1 ]
Maddux, B. [1 ]
Claros, C. [1 ]
Goldfine, I. [1 ]
Small, E. J. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15500
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase II trial of lapatinib (GW572016) in patients with recurrent prostate cancer as evident by a rising PSA
    Chen, Y.
    Wilding, G.
    Gee, J.
    DiPaola, R. P.
    Pins, M.
    Carducci, M. A.
    Stein, M. N.
    Bubley, G.
    Liu, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [22] Clinical evidence - Non-metastatic prostate cancer
    Wilt, TJ
    Brawer, MK
    WESTERN JOURNAL OF MEDICINE, 1999, 171 (02): : 97 - 101
  • [23] Role of bisphosphonates in non-metastatic prostate cancer
    Saad, Fred
    LANCET ONCOLOGY, 2014, 15 (10): : 1041 - 1042
  • [24] Oral enzastaurin in prostate cancer: A two-cohort phase II trial in patients with PSA progression in the non-metastatic castrate state and following docetaxel-based chemotherapy for castrate metastatic disease
    Robert Dreicer
    Jorge Garcia
    Maha Hussain
    Brian Rini
    Nicholas Vogelzang
    Sandy Srinivas
    Bradley Somer
    Yan D. Zhao
    Marek Kania
    Derek Raghavan
    Investigational New Drugs, 2011, 29 : 1441 - 1448
  • [25] Oral enzastaurin in prostate cancer: A two-cohort phase II trial in patients with PSA progression in the non-metastatic castrate state and following docetaxel-based chemotherapy for castrate metastatic disease
    Dreicer, Robert
    Garcia, Jorge
    Hussain, Maha
    Rini, Brian
    Vogelzang, Nicholas
    Srinivas, Sandy
    Somer, Bradley
    Zhao, Yan D.
    Kania, Marek
    Raghavan, Derek
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (06) : 1441 - 1448
  • [26] Phase I Trial of Stereotactic Body Radiotherapy Neoadjuvant to Radical Prostatectomy for Patients with Unfavorable and High-Risk Non-Metastatic Prostate Cancer: Feasibility And Safety
    Nickols, N. G.
    Kishan, A. U.
    Kane, N.
    Diaz-Perez, S.
    Ganapathy, E.
    Nazarian, R.
    Felix, C.
    Mathis, C.
    Kwak, J. Y.
    Basehart, V.
    Zomorodian, N.
    King, C. R.
    Kupelian, P. A.
    Rettig, M.
    Steinberg, M. L.
    Cao, M.
    Knudsen, B.
    Schaue, D.
    Reiter, R. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E298 - E298
  • [27] ADT/Abiraterone Acetate/Prednisolone for Patients with non-metastatic Prostate Cancer
    Di Lellis, Maddalena Angela
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (15) : 955 - 956
  • [28] Evaluating non -hormonal therapy in a phase II trial of SM-88 for rising PSA prostate cancer.
    Gartrell, Benjamin Adam
    Del Priore, Giuseppe
    Retter, Avi S.
    Chen, Wen-Tien
    Sokol, Gerald H.
    Vandell, Alexander G.
    Roach, Mack
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [29] Suicide and accidental deaths among patients with non-metastatic prostate cancer
    Dalela, Deepansh
    Krishna, Nandita
    Okwara, James
    Preston, Mark A.
    Abdollah, Firas
    Choueiri, Toni K.
    Reznor, Gally
    Sammon, Jesse D.
    Schmid, Marianne
    Kibel, Adam S.
    Nguyen, Paul L.
    Menon, Mani
    Trinh, Quoc-Dien
    BJU INTERNATIONAL, 2016, 118 (02) : 286 - 297
  • [30] UNSUSPECTED METASTASES FOUND DURING SCREENING FOR A TRIAL OF PATIENTS WITH NON-METASTATIC CASTRATION RESISTANT PROSTATE CANCER
    Crawford, E. David
    DePalantino, Jannell R.
    Kantoff, Philip W.
    Shore, Neal
    Underwood, Willie
    Reddy, Vijay
    Wang, Jim
    Mundle, Suneel
    Yang, Zane
    McGowan, Tracy
    Ryan, Charles J.
    JOURNAL OF UROLOGY, 2015, 193 (04): : E934 - E934
12345